|
Volumn 10, Issue 3, 2002, Pages 779-801
|
Novel potent 5-HT3 receptor ligands based on the pyrrolidone structure: Synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (1 AZABICYCLO[2.2.2]OCT 3 YL) 1,2 DIHYDRO 3H BENZ[E]ISOINDOL 3 ONE;
2 (1 AZABICYCLO[2.2.2]OCT 3 YL) 2,3 DIHYDRO 1H BENZ[E]ISOINDOL 1 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 1,2 DIHYDRO 3H BENZ[E]ISOINDOL 3 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 2,3 DIHYDRO 1H BENZ[E]ISOINDOL 1 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 2,3 DIHYDRO 1H BENZ[E]QUINOLIN 1 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 2,3 DIHYDRO 1H BENZ[F]ISOINDOL 1 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 2,3 DIHYDRO 1H ISOINDOL 1 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 2,3 DIHYDRO 1H PYRROLO[3,4 B]QUINOLIN 1 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 2,3 DIHYDRO 4 ETHOXY 1H PYRROLO[3,4 C]QUINOLIN 1 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 2,3 DIHYDRO 4 METHOXY 1H PYRROLO[3,4 C]QUINOLIN 1 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 2,3 DIHYDRO 4 PROPYLOXY 1H PYRROLO[3,4 C]QUINOLIN 1 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 2,3,3A,4,5,9B HEXAHYDRO 1H PYRROLO[3,4 C]QUINOLIN 1 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 2,3,4,5 TETRAHYDRO 5 PROPYL 1H PYRROLO[3,4 C]QUINOLIN 1,4 DIONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 4 CHLORO 2,3 DIHYDRO 1H PYRROLO[3,4 C]QUINOLIN 1 ONE;
2 (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3 YL) 9 CHLORO 2,3 DIHYDRO 1H PYRROLO[3,4 B]QUINOLIN 1 ONE;
GRANISETRON;
LIGAND;
PYRROLIDINE DERIVATIVE;
QUINUCLIDINE DERIVATIVE;
SCOPOLAMINE;
SEROTONIN 3 AGONIST;
SEROTONIN 3 ANTAGONIST;
SEROTONIN ANTAGONIST;
SEROTONIN RECEPTOR;
TROPANE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
2 PYRROLIDONE DERIVATIVE;
GUANIDINE;
SEROTONIN 3 RECEPTOR;
SEROTONIN RECEPTOR AFFECTING AGENT;
AMNESIA;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BINDING AFFINITY;
BIOASSAY;
BIOLOGY;
BRAIN MEMBRANE;
CALCULATION;
CARBON NUCLEAR MAGNETIC RESONANCE;
CELL STRAIN;
CHEMICAL INTERACTION;
COGNITIVE DEFECT;
CONTROLLED STUDY;
CRYSTAL STRUCTURE;
DEFENSE MECHANISM;
DRUG ACTIVITY;
DRUG BINDING;
DRUG INHIBITION;
DRUG SCREENING;
DRUG SYNTHESIS;
EVALUATION;
IN VITRO STUDY;
MALE;
METHODOLOGY;
NONHUMAN;
PROTEIN TRANSPORT;
PROTON NUCLEAR MAGNETIC RESONANCE;
QUALITATIVE ANALYSIS;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
RAT;
THEORETICAL STUDY;
THIN LAYER CHROMATOGRAPHY;
X RAY CRYSTALLOGRAPHY;
ANIMAL;
BINDING COMPETITION;
BINDING SITE;
BRADYCARDIA;
CELL CULTURE;
CHEMICALLY INDUCED DISORDER;
CHEMISTRY;
DOSE RESPONSE;
METABOLISM;
MOUSE;
SYNTHESIS;
AMNESIA;
ANIMALS;
BINDING SITES;
BINDING, COMPETITIVE;
BRADYCARDIA;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GUANIDINE;
LIGANDS;
MICE;
PYRROLIDINONES;
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;
RATS;
RECEPTORS, SEROTONIN;
RECEPTORS, SEROTONIN, 5-HT3;
SEROTONIN AGENTS;
TUMOR CELLS, CULTURED;
|
EID: 18244384253
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(01)00332-7 Document Type: Article |
Times cited : (36)
|
References (55)
|